Loading...

Purified anti-mouse CD45 Antibody Purified anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_Pure_071608.jpg
BALB/c splenocytes stained with 30-F11 purified, followed by anti-rat IgG FITC
  • 30-F11_Pure_071608.jpg
    BALB/c splenocytes stained with 30-F11 purified, followed by anti-rat IgG FITC
  • 30-F11_Pure_CD45_Antibody_2_102518
    Fresh, frozen mouse spleen was stained with purified CD45 clone 30-F11 conjugated and detected with a FITC CODEX™ oligonucleotide duplex (red). Samples were counterstained with CollagenIV Cy5 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
103101 50 µg NOK297
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103102 500 µg NOK941
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, CyTOF® - Verified
IP, CMCD, IHC, WB - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Davies M, et al. 2017. PLoS Pathogens. 13(6):e1006435. PubMed
  2. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  3. Schneider H, et al. 2017. J Neurochem. 140:170. PubMed
  4. Shafer MER, et al. 2017. Stem Cell Reports. 1.040277778. PubMed
  5. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  6. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  7. Tremblay M, et al. 2020. Elife. 9: . PubMed
  8. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  9. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  10. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  11. Moore J, et al. 2022. Cancer Res. 82:365. PubMed
  12. Park JY, et al. 2022. Cell Rep. 38:110219. PubMed
  13. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  14. Lee NK, et al. 2022. Biomedicines. 10: . PubMed
  15. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  16. Li S, et al. 2022. Nat Commun. 13:7371. PubMed
  17. Abby E, et al. 2023. Nat Genet. 55:232. PubMed
  18. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  19. Tarazi S, et al. 2022. Cell. 185:3290. PubMed
  20. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  21. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  22. García Fallit M, et al. 2023. Viruses. 15:. PubMed
  23. Xu J, et al. 2023. Discov Oncol. 14:68. PubMed
  24. Rafaiee R, et al. 2023. Bioimpacts. 13:97. PubMed
  25. Blomberg E, et al. 2022. Neurooncol Adv. 4:vdac148. PubMed
  26. Murai K, et al. 2022. Nat Commun. 13:6206. PubMed
  27. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  28. Claveria-Cabello A, et al. 2020. Cancers (Basel). 12:00. PubMed
  29. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  30. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  31. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  32. Widjaja AA, et al. 2019. Gastroenterology. 157:777. PubMed
  33. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  34. Fernandes V, et al. 2020. PLoS Pathog. 16:e1008464. PubMed
  35. Nguyen R, et al. 2021. Cancer Immunol Immunother. 70:721. PubMed
  36. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  37. Maestro S, et al. 2021. Viruses. 13: . PubMed
  38. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  39. Chamberlin T, et al. 2020. Cancer Research. 80(20):4465-4475. PubMed
  40. Li X, et al. 2020. Cell Rep. 31:107765. PubMed
  41. Vitiello GA, et al. 2018. Clin Cancer Res. 24:972. PubMed
  42. Rothchild AC, et al. 2019. Sci Immunol. 4:eaaw6693. PubMed
  43. Moon H et al. 2017. Cell stem cell. 21(5):665-678 . PubMed
  44. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  45. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  46. Goel S, et al. 2017. Nature. 548:471. PubMed
  47. Heinrich A, et al. 2021. Cell Rep. 37:109885. PubMed
  48. Cooper STE, et al. 2022. Int J Mol Sci. 23:. PubMed
  49. Deppermann C, et al. 2020. J Exp Med. 217:. PubMed
  50. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  51. Paulo E, et al. 2018. Sci Rep. 8:11001. PubMed
  52. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  53. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  54. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  55. Starossom SC, et al. 2019. Nat Commun. 10:217. PubMed
  56. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  57. Gao H, et al. 2021. J Virol. :. PubMed
  58. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  59. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  60. Liu X, et al. 2020. Nature. . PubMed
  61. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  62. Parlanti P, et al. 2020. Exp Eye Res. 194:107998. PubMed
  63. Lee S, et al. 2020. Cell Host & Microbe. 27(6):937-949. PubMed
  64. Zabaleta N, et al. 2018. Nat Commun. 9:5454. PubMed
  65. Zhu F, et al. 2019. J Immunol. 203:2644. PubMed
  66. Li Y et al. 2019. Endocrinology. 160(4):938-946 . PubMed
  67. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  68. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  69. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  70. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  71. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  72. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  73. Murad JP, et al. 2018. Front Immunol. 1.95. PubMed
  74. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  75. Sutton C, et al. 2017. Nat Commun.. 10.1038/s41467-017-02111-0. PubMed
  76. Janghorban M, et al. 2022. Cancer Res. 82:885. PubMed
  77. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  78. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  79. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  80. Baraibar-Churio A, et al. 2021. Life (Basel). 11:. PubMed
  81. Nam J, et al. 2021. Front Cell Neurosci. 15:640084. PubMed
  82. Park S, et al. 2021. Nat Cell Biol. 23:476. PubMed
  83. Podd B, et al. 2006. J Immunol. 176:6532. PubMed
  84. Hitchcock JR, et al. 2020. FEBS J. 287:250. PubMed
  85. Rhee S, et al. 2018. Nat Commun. 9:368. PubMed
  86. Finn J et al. 2019. Cell reports. 26(11):2942-2954 . PubMed
  87. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  88. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  89. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  90. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  91. Gil-Melgosa L, et al. 2021. Biomedicines. 10:. PubMed
  92. Hagan AS, et al. 2020. Development. 147:00:00. PubMed
  93. Fiege JK, et al. 2019. PLoS Pathog. 15:e1008077. PubMed
  94. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  95. Melchor SJ, et al. 2020. Sci Rep. 10:15724. PubMed
  96. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  97. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  98. Yim AKY, et al. 2022. Nat Neurosci. 25:238. PubMed
  99. Singh PP, et al. 2021. Ocul Surf. 21:271. PubMed
  100. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  101. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  102. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  103. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  104. Yoshihara S, et al. 2019. Front Immunol. 0.545833333. PubMed
  105. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  106. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  107. Bruno KA, et al. 2021. Int J Mol Sci. 22:. PubMed
  108. Crawford LB, et al. 2020. Microorganisms. 8:. PubMed
  109. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  110. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  111. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  112. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  113. Ito S, et al. 2020. PLoS One. 15:e0229888. PubMed
  114. Latasa M, et al. 2010. PLoS One. 5:e15690. PubMed
  115. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  116. Vu LT, et al. 2019. J Extracell Vesicles. 8:1599680. PubMed
  117. Jones KB et al. 2018. Cell stem cell. 24(1):183-192 . PubMed
  118. Zhong L, et al. 2022. JCI Insight. 7:. PubMed
  119. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  120. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  121. Qiu X, et al. 2018. Lab Chip. 18:2776. PubMed
  122. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  123. Murai K et al. 2018. Cell stem cell. 23(5):687-699 . PubMed
  124. Morita S et al. 2017. Cell metabolism. 25(4):883-897 . PubMed
  125. Sheppard S, et al. 2018. Front Immunol. 1.630555556. PubMed
  126. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  127. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  128. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  129. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  130. Hashimoto M, et al. 2021. J Neurochem. 156:834. PubMed
  131. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  132. Nikolaou K, et al. 2014. EMBO J. 34:430. PubMed
  133. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  134. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  135. Poulos MG, et al. 2017. J Clin Invest. 127:4163. PubMed
  136. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  137. Lopes N, et al. 2021. Nat Immunol. 22:179. PubMed
  138. Perdigoto AL, et al. 2022. JCI Insight. 7:. PubMed
  139. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  140. Hu CF, et al. 2021. Front Immunol. 12:638381. PubMed
  141. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  142. Chen Q, et al. 2021. STAR Protocols. 2(1):100241. PubMed
  143. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  144. Bar O, et al. 2020. Fluids Barriers CNS. 17:27. PubMed
  145. Langer V, et al. 2019. J Clin Invest. 129:4691. PubMed
  146. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  147. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  148. Geng T, et al. 2021. J Infect Dis. 223:2186. PubMed
  149. Ishigaki K, et al. 2021. Sci Rep. 11:13958. PubMed
  150. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  151. Somasundaram R, et al. 2021. Blood. 137:3037. PubMed
  152. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
  153. Yu W, et al. 2020. J Clin Invest. . PubMed
  154. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  155. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  156. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  157. Wang Z, et al. 2021. Drug Discov Ther. 14:304. PubMed
  158. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  159. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  160. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  161. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  162. Fahy N, et al. 2021. Front Immunol. 12:715267. PubMed
  163. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  164. Mori Y, et al. 2021. Diabetes and Vascular Disease Research. 18(3):14791641211027324. PubMed
  165. Dora D, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1617. PubMed
  166. Cha J, et al. 2015. J Biol Chem. 290:15337. PubMed
  167. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  168. Tamburini BAJ, et al. 2019. Front Immunol. 10:1036. PubMed
  169. Deng W et al. 2019. Cell reports. 27(6):1755-1768 . PubMed
  170. Van Der Zande HJP, et al. 2021. FASEB J. 35:e21331. PubMed
  171. Penny HL, et al. 2021. Int J Mol Sci. 22:. PubMed
  172. Rincón E, et al. 2017. Oncotarget. 8:45415. PubMed
  173. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  174. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  175. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  176. Li Y, et al. 2020. Elife. 9:00. PubMed
  177. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  178. DeFalco T, et al. 2014. Proc Natl Acad Sci U S A. 111:2384. PubMed
  179. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  180. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  181. Heinrich A, et al. 2020. Cell Rep. 31:107513. PubMed
  182. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  183. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  184. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  185. Stokes KL, et al. 2019. Oncogenesis. 8:24. PubMed
  186. Krenzlin H, et al. 2019. J Clin Invest. 130:1671. PubMed
  187. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  188. Huppé CA, et al. 2018. Mucosal Immunol. 0.536111111. PubMed
  189. Van Winkle JA, et al. 2020. J Virol. 94:. PubMed
  190. Maier B, et al. 2020. Nature. 580:257. PubMed
  191. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  192. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  193. Bernard S, et al. 2018. J Mammary Gland Biol Neoplasia. 23:249. PubMed
  194. Hassel C, et al. 2021. Front Immunol. 12:754661. PubMed
  195. Obst J, et al. 2020. Front Immunol. 11:579000. PubMed
  196. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  197. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  198. Leist SR, et al. 2019. PLoS One. 14:e0220126. PubMed
  199. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  200. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  201. Haber AL, et al. 2017. Nature. 551:333. PubMed
  202. Emrick JJ, et al. 2018. Proc Natl Acad Sci U S A. 115:E12091. PubMed
  203. Seehus CR, et al. 2017. Nat Commun. 8:1900. PubMed
  204. Cédile O, Wlodarczyk A, and Owens T 2017. APMIS.. 10.1111/apm.12740. PubMed
  205. Wilke JBH, et al. 2021. Mol Psychiatry. 26:7746. PubMed
  206. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  207. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  208. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  209. Davies M, et al. 2017. PLoS Pathogens. 13(6):e1006435. PubMed
  210. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  211. Schneider H, et al. 2017. J Neurochem. 140:170. PubMed
  212. Shafer MER, et al. 2017. Stem Cell Reports. 1.040277778. PubMed
  213. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  214. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  215. Tremblay M, et al. 2020. Elife. 9: . PubMed
  216. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  217. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  218. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  219. Moore J, et al. 2022. Cancer Res. 82:365. PubMed
  220. Park JY, et al. 2022. Cell Rep. 38:110219. PubMed
  221. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  222. Lee NK, et al. 2022. Biomedicines. 10: . PubMed
  223. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  224. Li S, et al. 2022. Nat Commun. 13:7371. PubMed
  225. Abby E, et al. 2023. Nat Genet. 55:232. PubMed
  226. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  227. Tarazi S, et al. 2022. Cell. 185:3290. PubMed
  228. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  229. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  230. García Fallit M, et al. 2023. Viruses. 15:. PubMed
  231. Xu J, et al. 2023. Discov Oncol. 14:68. PubMed
  232. Rafaiee R, et al. 2023. Bioimpacts. 13:97. PubMed
  233. Blomberg E, et al. 2022. Neurooncol Adv. 4:vdac148. PubMed
  234. Murai K, et al. 2022. Nat Commun. 13:6206. PubMed
  235. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  236. Claveria-Cabello A, et al. 2020. Cancers (Basel). 12:00. PubMed
  237. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  238. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  239. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  240. Widjaja AA, et al. 2019. Gastroenterology. 157:777. PubMed
  241. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  242. Fernandes V, et al. 2020. PLoS Pathog. 16:e1008464. PubMed
  243. Nguyen R, et al. 2021. Cancer Immunol Immunother. 70:721. PubMed
  244. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  245. Maestro S, et al. 2021. Viruses. 13: . PubMed
  246. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  247. Chamberlin T, et al. 2020. Cancer Research. 80(20):4465-4475. PubMed
  248. Li X, et al. 2020. Cell Rep. 31:107765. PubMed
  249. Vitiello GA, et al. 2018. Clin Cancer Res. 24:972. PubMed
  250. Rothchild AC, et al. 2019. Sci Immunol. 4:eaaw6693. PubMed
  251. Moon H et al. 2017. Cell stem cell. 21(5):665-678 . PubMed
  252. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  253. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  254. Goel S, et al. 2017. Nature. 548:471. PubMed
  255. Heinrich A, et al. 2021. Cell Rep. 37:109885. PubMed
  256. Cooper STE, et al. 2022. Int J Mol Sci. 23:. PubMed
  257. Deppermann C, et al. 2020. J Exp Med. 217:. PubMed
  258. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  259. Paulo E, et al. 2018. Sci Rep. 8:11001. PubMed
  260. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  261. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  262. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  263. Starossom SC, et al. 2019. Nat Commun. 10:217. PubMed
  264. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  265. Gao H, et al. 2021. J Virol. :. PubMed
  266. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  267. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  268. Liu X, et al. 2020. Nature. . PubMed
  269. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  270. Parlanti P, et al. 2020. Exp Eye Res. 194:107998. PubMed
  271. Lee S, et al. 2020. Cell Host & Microbe. 27(6):937-949. PubMed
  272. Zabaleta N, et al. 2018. Nat Commun. 9:5454. PubMed
  273. Zhu F, et al. 2019. J Immunol. 203:2644. PubMed
  274. Li Y et al. 2019. Endocrinology. 160(4):938-946 . PubMed
  275. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  276. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  277. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  278. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  279. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  280. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  281. Murad JP, et al. 2018. Front Immunol. 1.95. PubMed
  282. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  283. Sutton C, et al. 2017. Nat Commun.. 10.1038/s41467-017-02111-0. PubMed
  284. Janghorban M, et al. 2022. Cancer Res. 82:885. PubMed
  285. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  286. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  287. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  288. Baraibar-Churio A, et al. 2021. Life (Basel). 11:. PubMed
  289. Nam J, et al. 2021. Front Cell Neurosci. 15:640084. PubMed
  290. Park S, et al. 2021. Nat Cell Biol. 23:476. PubMed
  291. Podd B, et al. 2006. J Immunol. 176:6532. PubMed
  292. Hitchcock JR, et al. 2020. FEBS J. 287:250. PubMed
  293. Rhee S, et al. 2018. Nat Commun. 9:368. PubMed
  294. Finn J et al. 2019. Cell reports. 26(11):2942-2954 . PubMed
  295. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  296. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  297. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  298. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  299. Gil-Melgosa L, et al. 2021. Biomedicines. 10:. PubMed
  300. Hagan AS, et al. 2020. Development. 147:00:00. PubMed
  301. Fiege JK, et al. 2019. PLoS Pathog. 15:e1008077. PubMed
  302. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  303. Melchor SJ, et al. 2020. Sci Rep. 10:15724. PubMed
  304. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  305. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  306. Yim AKY, et al. 2022. Nat Neurosci. 25:238. PubMed
  307. Singh PP, et al. 2021. Ocul Surf. 21:271. PubMed
  308. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  309. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  310. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  311. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  312. Yoshihara S, et al. 2019. Front Immunol. 0.545833333. PubMed
  313. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  314. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  315. Bruno KA, et al. 2021. Int J Mol Sci. 22:. PubMed
  316. Crawford LB, et al. 2020. Microorganisms. 8:. PubMed
  317. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  318. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  319. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  320. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  321. Ito S, et al. 2020. PLoS One. 15:e0229888. PubMed
  322. Latasa M, et al. 2010. PLoS One. 5:e15690. PubMed
  323. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  324. Vu LT, et al. 2019. J Extracell Vesicles. 8:1599680. PubMed
  325. Jones KB et al. 2018. Cell stem cell. 24(1):183-192 . PubMed
  326. Zhong L, et al. 2022. JCI Insight. 7:. PubMed
  327. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  328. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  329. Qiu X, et al. 2018. Lab Chip. 18:2776. PubMed
  330. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  331. Murai K et al. 2018. Cell stem cell. 23(5):687-699 . PubMed
  332. Morita S et al. 2017. Cell metabolism. 25(4):883-897 . PubMed
  333. Sheppard S, et al. 2018. Front Immunol. 1.630555556. PubMed
  334. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  335. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  336. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  337. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  338. Hashimoto M, et al. 2021. J Neurochem. 156:834. PubMed
  339. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  340. Nikolaou K, et al. 2014. EMBO J. 34:430. PubMed
  341. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  342. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  343. Poulos MG, et al. 2017. J Clin Invest. 127:4163. PubMed
  344. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  345. Lopes N, et al. 2021. Nat Immunol. 22:179. PubMed
  346. Perdigoto AL, et al. 2022. JCI Insight. 7:. PubMed
  347. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  348. Hu CF, et al. 2021. Front Immunol. 12:638381. PubMed
  349. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  350. Chen Q, et al. 2021. STAR Protocols. 2(1):100241. PubMed
  351. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  352. Bar O, et al. 2020. Fluids Barriers CNS. 17:27. PubMed
  353. Langer V, et al. 2019. J Clin Invest. 129:4691. PubMed
  354. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  355. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  356. Geng T, et al. 2021. J Infect Dis. 223:2186. PubMed
  357. Ishigaki K, et al. 2021. Sci Rep. 11:13958. PubMed
  358. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  359. Somasundaram R, et al. 2021. Blood. 137:3037. PubMed
  360. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
  361. Yu W, et al. 2020. J Clin Invest. . PubMed
  362. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  363. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  364. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  365. Wang Z, et al. 2021. Drug Discov Ther. 14:304. PubMed
  366. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  367. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  368. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  369. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  370. Fahy N, et al. 2021. Front Immunol. 12:715267. PubMed
  371. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  372. Mori Y, et al. 2021. Diabetes and Vascular Disease Research. 18(3):14791641211027324. PubMed
  373. Dora D, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1617. PubMed
  374. Cha J, et al. 2015. J Biol Chem. 290:15337. PubMed
  375. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  376. Tamburini BAJ, et al. 2019. Front Immunol. 10:1036. PubMed
  377. Deng W et al. 2019. Cell reports. 27(6):1755-1768 . PubMed
  378. Van Der Zande HJP, et al. 2021. FASEB J. 35:e21331. PubMed
  379. Penny HL, et al. 2021. Int J Mol Sci. 22:. PubMed
  380. Rincón E, et al. 2017. Oncotarget. 8:45415. PubMed
  381. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  382. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  383. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  384. Li Y, et al. 2020. Elife. 9:00. PubMed
  385. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  386. DeFalco T, et al. 2014. Proc Natl Acad Sci U S A. 111:2384. PubMed
  387. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  388. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  389. Heinrich A, et al. 2020. Cell Rep. 31:107513. PubMed
  390. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  391. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  392. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  393. Stokes KL, et al. 2019. Oncogenesis. 8:24. PubMed
  394. Krenzlin H, et al. 2019. J Clin Invest. 130:1671. PubMed
  395. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  396. Huppé CA, et al. 2018. Mucosal Immunol. 0.536111111. PubMed
  397. Van Winkle JA, et al. 2020. J Virol. 94:. PubMed
  398. Maier B, et al. 2020. Nature. 580:257. PubMed
  399. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  400. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  401. Bernard S, et al. 2018. J Mammary Gland Biol Neoplasia. 23:249. PubMed
  402. Hassel C, et al. 2021. Front Immunol. 12:754661. PubMed
  403. Obst J, et al. 2020. Front Immunol. 11:579000. PubMed
  404. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  405. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  406. Leist SR, et al. 2019. PLoS One. 14:e0220126. PubMed
  407. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  408. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  409. Haber AL, et al. 2017. Nature. 551:333. PubMed
  410. Emrick JJ, et al. 2018. Proc Natl Acad Sci U S A. 115:E12091. PubMed
  411. Seehus CR, et al. 2017. Nat Commun. 8:1900. PubMed
  412. Cédile O, Wlodarczyk A, and Owens T 2017. APMIS.. 10.1111/apm.12740. PubMed
  413. Wilke JBH, et al. 2021. Mol Psychiatry. 26:7746. PubMed
  414. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  415. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  416. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
RRID
AB_312966 (BioLegend Cat. No. 103101)
AB_312967 (BioLegend Cat. No. 103102)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 10.25.2018

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_Pure_071608.jpg
BALB/c splenocytes stained with 30-F11 purified, followed by anti-rat IgG FITC
  • 30-F11_Pure_071608.jpg
    BALB/c splenocytes stained with 30-F11 purified, followed by anti-rat IgG FITC
  • 30-F11_Pure_CD45_Antibody_2_102518
    Fresh, frozen mouse spleen was stained with purified CD45 clone 30-F11 conjugated and detected with a FITC CODEX™ oligonucleotide duplex (red). Samples were counterstained with CollagenIV Cy5 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
103101 50 µg NOK297
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103102 500 µg NOK941
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, CyTOF® - Verified
IP, CMCD, IHC, WB - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Davies M, et al. 2017. PLoS Pathogens. 13(6):e1006435. PubMed
  2. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  3. Schneider H, et al. 2017. J Neurochem. 140:170. PubMed
  4. Shafer MER, et al. 2017. Stem Cell Reports. 1.040277778. PubMed
  5. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  6. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  7. Tremblay M, et al. 2020. Elife. 9: . PubMed
  8. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  9. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  10. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  11. Moore J, et al. 2022. Cancer Res. 82:365. PubMed
  12. Park JY, et al. 2022. Cell Rep. 38:110219. PubMed
  13. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  14. Lee NK, et al. 2022. Biomedicines. 10: . PubMed
  15. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  16. Li S, et al. 2022. Nat Commun. 13:7371. PubMed
  17. Abby E, et al. 2023. Nat Genet. 55:232. PubMed
  18. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  19. Tarazi S, et al. 2022. Cell. 185:3290. PubMed
  20. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  21. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  22. García Fallit M, et al. 2023. Viruses. 15:. PubMed
  23. Xu J, et al. 2023. Discov Oncol. 14:68. PubMed
  24. Rafaiee R, et al. 2023. Bioimpacts. 13:97. PubMed
  25. Blomberg E, et al. 2022. Neurooncol Adv. 4:vdac148. PubMed
  26. Murai K, et al. 2022. Nat Commun. 13:6206. PubMed
  27. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  28. Claveria-Cabello A, et al. 2020. Cancers (Basel). 12:00. PubMed
  29. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  30. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  31. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  32. Widjaja AA, et al. 2019. Gastroenterology. 157:777. PubMed
  33. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  34. Fernandes V, et al. 2020. PLoS Pathog. 16:e1008464. PubMed
  35. Nguyen R, et al. 2021. Cancer Immunol Immunother. 70:721. PubMed
  36. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  37. Maestro S, et al. 2021. Viruses. 13: . PubMed
  38. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  39. Chamberlin T, et al. 2020. Cancer Research. 80(20):4465-4475. PubMed
  40. Li X, et al. 2020. Cell Rep. 31:107765. PubMed
  41. Vitiello GA, et al. 2018. Clin Cancer Res. 24:972. PubMed
  42. Rothchild AC, et al. 2019. Sci Immunol. 4:eaaw6693. PubMed
  43. Moon H et al. 2017. Cell stem cell. 21(5):665-678 . PubMed
  44. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  45. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  46. Goel S, et al. 2017. Nature. 548:471. PubMed
  47. Heinrich A, et al. 2021. Cell Rep. 37:109885. PubMed
  48. Cooper STE, et al. 2022. Int J Mol Sci. 23:. PubMed
  49. Deppermann C, et al. 2020. J Exp Med. 217:. PubMed
  50. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  51. Paulo E, et al. 2018. Sci Rep. 8:11001. PubMed
  52. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  53. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  54. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  55. Starossom SC, et al. 2019. Nat Commun. 10:217. PubMed
  56. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  57. Gao H, et al. 2021. J Virol. :. PubMed
  58. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  59. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  60. Liu X, et al. 2020. Nature. . PubMed
  61. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  62. Parlanti P, et al. 2020. Exp Eye Res. 194:107998. PubMed
  63. Lee S, et al. 2020. Cell Host & Microbe. 27(6):937-949. PubMed
  64. Zabaleta N, et al. 2018. Nat Commun. 9:5454. PubMed
  65. Zhu F, et al. 2019. J Immunol. 203:2644. PubMed
  66. Li Y et al. 2019. Endocrinology. 160(4):938-946 . PubMed
  67. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  68. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  69. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  70. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  71. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  72. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  73. Murad JP, et al. 2018. Front Immunol. 1.95. PubMed
  74. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  75. Sutton C, et al. 2017. Nat Commun.. 10.1038/s41467-017-02111-0. PubMed
  76. Janghorban M, et al. 2022. Cancer Res. 82:885. PubMed
  77. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  78. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  79. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  80. Baraibar-Churio A, et al. 2021. Life (Basel). 11:. PubMed
  81. Nam J, et al. 2021. Front Cell Neurosci. 15:640084. PubMed
  82. Park S, et al. 2021. Nat Cell Biol. 23:476. PubMed
  83. Podd B, et al. 2006. J Immunol. 176:6532. PubMed
  84. Hitchcock JR, et al. 2020. FEBS J. 287:250. PubMed
  85. Rhee S, et al. 2018. Nat Commun. 9:368. PubMed
  86. Finn J et al. 2019. Cell reports. 26(11):2942-2954 . PubMed
  87. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  88. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  89. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  90. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  91. Gil-Melgosa L, et al. 2021. Biomedicines. 10:. PubMed
  92. Hagan AS, et al. 2020. Development. 147:00:00. PubMed
  93. Fiege JK, et al. 2019. PLoS Pathog. 15:e1008077. PubMed
  94. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  95. Melchor SJ, et al. 2020. Sci Rep. 10:15724. PubMed
  96. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  97. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  98. Yim AKY, et al. 2022. Nat Neurosci. 25:238. PubMed
  99. Singh PP, et al. 2021. Ocul Surf. 21:271. PubMed
  100. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  101. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  102. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  103. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  104. Yoshihara S, et al. 2019. Front Immunol. 0.545833333. PubMed
  105. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  106. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  107. Bruno KA, et al. 2021. Int J Mol Sci. 22:. PubMed
  108. Crawford LB, et al. 2020. Microorganisms. 8:. PubMed
  109. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  110. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  111. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  112. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  113. Ito S, et al. 2020. PLoS One. 15:e0229888. PubMed
  114. Latasa M, et al. 2010. PLoS One. 5:e15690. PubMed
  115. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  116. Vu LT, et al. 2019. J Extracell Vesicles. 8:1599680. PubMed
  117. Jones KB et al. 2018. Cell stem cell. 24(1):183-192 . PubMed
  118. Zhong L, et al. 2022. JCI Insight. 7:. PubMed
  119. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  120. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  121. Qiu X, et al. 2018. Lab Chip. 18:2776. PubMed
  122. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  123. Murai K et al. 2018. Cell stem cell. 23(5):687-699 . PubMed
  124. Morita S et al. 2017. Cell metabolism. 25(4):883-897 . PubMed
  125. Sheppard S, et al. 2018. Front Immunol. 1.630555556. PubMed
  126. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  127. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  128. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  129. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  130. Hashimoto M, et al. 2021. J Neurochem. 156:834. PubMed
  131. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  132. Nikolaou K, et al. 2014. EMBO J. 34:430. PubMed
  133. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  134. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  135. Poulos MG, et al. 2017. J Clin Invest. 127:4163. PubMed
  136. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  137. Lopes N, et al. 2021. Nat Immunol. 22:179. PubMed
  138. Perdigoto AL, et al. 2022. JCI Insight. 7:. PubMed
  139. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  140. Hu CF, et al. 2021. Front Immunol. 12:638381. PubMed
  141. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  142. Chen Q, et al. 2021. STAR Protocols. 2(1):100241. PubMed
  143. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  144. Bar O, et al. 2020. Fluids Barriers CNS. 17:27. PubMed
  145. Langer V, et al. 2019. J Clin Invest. 129:4691. PubMed
  146. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  147. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  148. Geng T, et al. 2021. J Infect Dis. 223:2186. PubMed
  149. Ishigaki K, et al. 2021. Sci Rep. 11:13958. PubMed
  150. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  151. Somasundaram R, et al. 2021. Blood. 137:3037. PubMed
  152. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
  153. Yu W, et al. 2020. J Clin Invest. . PubMed
  154. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  155. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  156. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  157. Wang Z, et al. 2021. Drug Discov Ther. 14:304. PubMed
  158. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  159. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  160. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  161. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  162. Fahy N, et al. 2021. Front Immunol. 12:715267. PubMed
  163. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  164. Mori Y, et al. 2021. Diabetes and Vascular Disease Research. 18(3):14791641211027324. PubMed
  165. Dora D, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1617. PubMed
  166. Cha J, et al. 2015. J Biol Chem. 290:15337. PubMed
  167. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  168. Tamburini BAJ, et al. 2019. Front Immunol. 10:1036. PubMed
  169. Deng W et al. 2019. Cell reports. 27(6):1755-1768 . PubMed
  170. Van Der Zande HJP, et al. 2021. FASEB J. 35:e21331. PubMed
  171. Penny HL, et al. 2021. Int J Mol Sci. 22:. PubMed
  172. Rincón E, et al. 2017. Oncotarget. 8:45415. PubMed
  173. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  174. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  175. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  176. Li Y, et al. 2020. Elife. 9:00. PubMed
  177. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  178. DeFalco T, et al. 2014. Proc Natl Acad Sci U S A. 111:2384. PubMed
  179. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  180. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  181. Heinrich A, et al. 2020. Cell Rep. 31:107513. PubMed
  182. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  183. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  184. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  185. Stokes KL, et al. 2019. Oncogenesis. 8:24. PubMed
  186. Krenzlin H, et al. 2019. J Clin Invest. 130:1671. PubMed
  187. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  188. Huppé CA, et al. 2018. Mucosal Immunol. 0.536111111. PubMed
  189. Van Winkle JA, et al. 2020. J Virol. 94:. PubMed
  190. Maier B, et al. 2020. Nature. 580:257. PubMed
  191. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  192. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  193. Bernard S, et al. 2018. J Mammary Gland Biol Neoplasia. 23:249. PubMed
  194. Hassel C, et al. 2021. Front Immunol. 12:754661. PubMed
  195. Obst J, et al. 2020. Front Immunol. 11:579000. PubMed
  196. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  197. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  198. Leist SR, et al. 2019. PLoS One. 14:e0220126. PubMed
  199. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  200. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  201. Haber AL, et al. 2017. Nature. 551:333. PubMed
  202. Emrick JJ, et al. 2018. Proc Natl Acad Sci U S A. 115:E12091. PubMed
  203. Seehus CR, et al. 2017. Nat Commun. 8:1900. PubMed
  204. Cédile O, Wlodarczyk A, and Owens T 2017. APMIS.. 10.1111/apm.12740. PubMed
  205. Wilke JBH, et al. 2021. Mol Psychiatry. 26:7746. PubMed
  206. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  207. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  208. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  209. Davies M, et al. 2017. PLoS Pathogens. 13(6):e1006435. PubMed
  210. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  211. Schneider H, et al. 2017. J Neurochem. 140:170. PubMed
  212. Shafer MER, et al. 2017. Stem Cell Reports. 1.040277778. PubMed
  213. Li F, et al. 2020. EMBO J. 39:e103205. PubMed
  214. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  215. Tremblay M, et al. 2020. Elife. 9: . PubMed
  216. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  217. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  218. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  219. Moore J, et al. 2022. Cancer Res. 82:365. PubMed
  220. Park JY, et al. 2022. Cell Rep. 38:110219. PubMed
  221. Valet C, et al. 2022. J Clin Invest. 132: . PubMed
  222. Lee NK, et al. 2022. Biomedicines. 10: . PubMed
  223. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  224. Li S, et al. 2022. Nat Commun. 13:7371. PubMed
  225. Abby E, et al. 2023. Nat Genet. 55:232. PubMed
  226. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  227. Tarazi S, et al. 2022. Cell. 185:3290. PubMed
  228. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  229. Wang Y, et al. 2023. J Neuroinflammation. 20:41. PubMed
  230. García Fallit M, et al. 2023. Viruses. 15:. PubMed
  231. Xu J, et al. 2023. Discov Oncol. 14:68. PubMed
  232. Rafaiee R, et al. 2023. Bioimpacts. 13:97. PubMed
  233. Blomberg E, et al. 2022. Neurooncol Adv. 4:vdac148. PubMed
  234. Murai K, et al. 2022. Nat Commun. 13:6206. PubMed
  235. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  236. Claveria-Cabello A, et al. 2020. Cancers (Basel). 12:00. PubMed
  237. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  238. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  239. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  240. Widjaja AA, et al. 2019. Gastroenterology. 157:777. PubMed
  241. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  242. Fernandes V, et al. 2020. PLoS Pathog. 16:e1008464. PubMed
  243. Nguyen R, et al. 2021. Cancer Immunol Immunother. 70:721. PubMed
  244. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  245. Maestro S, et al. 2021. Viruses. 13: . PubMed
  246. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  247. Chamberlin T, et al. 2020. Cancer Research. 80(20):4465-4475. PubMed
  248. Li X, et al. 2020. Cell Rep. 31:107765. PubMed
  249. Vitiello GA, et al. 2018. Clin Cancer Res. 24:972. PubMed
  250. Rothchild AC, et al. 2019. Sci Immunol. 4:eaaw6693. PubMed
  251. Moon H et al. 2017. Cell stem cell. 21(5):665-678 . PubMed
  252. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  253. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  254. Goel S, et al. 2017. Nature. 548:471. PubMed
  255. Heinrich A, et al. 2021. Cell Rep. 37:109885. PubMed
  256. Cooper STE, et al. 2022. Int J Mol Sci. 23:. PubMed
  257. Deppermann C, et al. 2020. J Exp Med. 217:. PubMed
  258. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  259. Paulo E, et al. 2018. Sci Rep. 8:11001. PubMed
  260. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  261. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  262. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  263. Starossom SC, et al. 2019. Nat Commun. 10:217. PubMed
  264. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  265. Gao H, et al. 2021. J Virol. :. PubMed
  266. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  267. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  268. Liu X, et al. 2020. Nature. . PubMed
  269. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  270. Parlanti P, et al. 2020. Exp Eye Res. 194:107998. PubMed
  271. Lee S, et al. 2020. Cell Host & Microbe. 27(6):937-949. PubMed
  272. Zabaleta N, et al. 2018. Nat Commun. 9:5454. PubMed
  273. Zhu F, et al. 2019. J Immunol. 203:2644. PubMed
  274. Li Y et al. 2019. Endocrinology. 160(4):938-946 . PubMed
  275. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  276. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  277. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  278. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  279. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  280. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  281. Murad JP, et al. 2018. Front Immunol. 1.95. PubMed
  282. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  283. Sutton C, et al. 2017. Nat Commun.. 10.1038/s41467-017-02111-0. PubMed
  284. Janghorban M, et al. 2022. Cancer Res. 82:885. PubMed
  285. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  286. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  287. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  288. Baraibar-Churio A, et al. 2021. Life (Basel). 11:. PubMed
  289. Nam J, et al. 2021. Front Cell Neurosci. 15:640084. PubMed
  290. Park S, et al. 2021. Nat Cell Biol. 23:476. PubMed
  291. Podd B, et al. 2006. J Immunol. 176:6532. PubMed
  292. Hitchcock JR, et al. 2020. FEBS J. 287:250. PubMed
  293. Rhee S, et al. 2018. Nat Commun. 9:368. PubMed
  294. Finn J et al. 2019. Cell reports. 26(11):2942-2954 . PubMed
  295. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  296. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  297. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  298. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  299. Gil-Melgosa L, et al. 2021. Biomedicines. 10:. PubMed
  300. Hagan AS, et al. 2020. Development. 147:00:00. PubMed
  301. Fiege JK, et al. 2019. PLoS Pathog. 15:e1008077. PubMed
  302. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  303. Melchor SJ, et al. 2020. Sci Rep. 10:15724. PubMed
  304. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  305. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  306. Yim AKY, et al. 2022. Nat Neurosci. 25:238. PubMed
  307. Singh PP, et al. 2021. Ocul Surf. 21:271. PubMed
  308. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  309. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  310. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  311. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  312. Yoshihara S, et al. 2019. Front Immunol. 0.545833333. PubMed
  313. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  314. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  315. Bruno KA, et al. 2021. Int J Mol Sci. 22:. PubMed
  316. Crawford LB, et al. 2020. Microorganisms. 8:. PubMed
  317. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  318. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  319. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  320. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  321. Ito S, et al. 2020. PLoS One. 15:e0229888. PubMed
  322. Latasa M, et al. 2010. PLoS One. 5:e15690. PubMed
  323. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  324. Vu LT, et al. 2019. J Extracell Vesicles. 8:1599680. PubMed
  325. Jones KB et al. 2018. Cell stem cell. 24(1):183-192 . PubMed
  326. Zhong L, et al. 2022. JCI Insight. 7:. PubMed
  327. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  328. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  329. Qiu X, et al. 2018. Lab Chip. 18:2776. PubMed
  330. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  331. Murai K et al. 2018. Cell stem cell. 23(5):687-699 . PubMed
  332. Morita S et al. 2017. Cell metabolism. 25(4):883-897 . PubMed
  333. Sheppard S, et al. 2018. Front Immunol. 1.630555556. PubMed
  334. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  335. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  336. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  337. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  338. Hashimoto M, et al. 2021. J Neurochem. 156:834. PubMed
  339. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  340. Nikolaou K, et al. 2014. EMBO J. 34:430. PubMed
  341. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  342. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  343. Poulos MG, et al. 2017. J Clin Invest. 127:4163. PubMed
  344. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  345. Lopes N, et al. 2021. Nat Immunol. 22:179. PubMed
  346. Perdigoto AL, et al. 2022. JCI Insight. 7:. PubMed
  347. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  348. Hu CF, et al. 2021. Front Immunol. 12:638381. PubMed
  349. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  350. Chen Q, et al. 2021. STAR Protocols. 2(1):100241. PubMed
  351. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  352. Bar O, et al. 2020. Fluids Barriers CNS. 17:27. PubMed
  353. Langer V, et al. 2019. J Clin Invest. 129:4691. PubMed
  354. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  355. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  356. Geng T, et al. 2021. J Infect Dis. 223:2186. PubMed
  357. Ishigaki K, et al. 2021. Sci Rep. 11:13958. PubMed
  358. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  359. Somasundaram R, et al. 2021. Blood. 137:3037. PubMed
  360. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
  361. Yu W, et al. 2020. J Clin Invest. . PubMed
  362. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  363. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  364. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  365. Wang Z, et al. 2021. Drug Discov Ther. 14:304. PubMed
  366. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  367. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  368. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  369. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  370. Fahy N, et al. 2021. Front Immunol. 12:715267. PubMed
  371. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  372. Mori Y, et al. 2021. Diabetes and Vascular Disease Research. 18(3):14791641211027324. PubMed
  373. Dora D, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1617. PubMed
  374. Cha J, et al. 2015. J Biol Chem. 290:15337. PubMed
  375. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  376. Tamburini BAJ, et al. 2019. Front Immunol. 10:1036. PubMed
  377. Deng W et al. 2019. Cell reports. 27(6):1755-1768 . PubMed
  378. Van Der Zande HJP, et al. 2021. FASEB J. 35:e21331. PubMed
  379. Penny HL, et al. 2021. Int J Mol Sci. 22:. PubMed
  380. Rincón E, et al. 2017. Oncotarget. 8:45415. PubMed
  381. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  382. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  383. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  384. Li Y, et al. 2020. Elife. 9:00. PubMed
  385. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  386. DeFalco T, et al. 2014. Proc Natl Acad Sci U S A. 111:2384. PubMed
  387. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  388. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  389. Heinrich A, et al. 2020. Cell Rep. 31:107513. PubMed
  390. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  391. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  392. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  393. Stokes KL, et al. 2019. Oncogenesis. 8:24. PubMed
  394. Krenzlin H, et al. 2019. J Clin Invest. 130:1671. PubMed
  395. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  396. Huppé CA, et al. 2018. Mucosal Immunol. 0.536111111. PubMed
  397. Van Winkle JA, et al. 2020. J Virol. 94:. PubMed
  398. Maier B, et al. 2020. Nature. 580:257. PubMed
  399. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  400. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  401. Bernard S, et al. 2018. J Mammary Gland Biol Neoplasia. 23:249. PubMed
  402. Hassel C, et al. 2021. Front Immunol. 12:754661. PubMed
  403. Obst J, et al. 2020. Front Immunol. 11:579000. PubMed
  404. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  405. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  406. Leist SR, et al. 2019. PLoS One. 14:e0220126. PubMed
  407. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  408. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  409. Haber AL, et al. 2017. Nature. 551:333. PubMed
  410. Emrick JJ, et al. 2018. Proc Natl Acad Sci U S A. 115:E12091. PubMed
  411. Seehus CR, et al. 2017. Nat Commun. 8:1900. PubMed
  412. Cédile O, Wlodarczyk A, and Owens T 2017. APMIS.. 10.1111/apm.12740. PubMed
  413. Wilke JBH, et al. 2021. Mol Psychiatry. 26:7746. PubMed
  414. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  415. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  416. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
RRID
AB_312966 (BioLegend Cat. No. 103101)
AB_312967 (BioLegend Cat. No. 103102)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 10.25.2018

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account